STAT+: Arkansas becomes the latest state to sue drugmakers and PBMs over insulin pricing

“These drug manufacturers and PBMs have inflated the price of insulin and other diabetes-related medication to the line their own pockets,” said Arkansas Attorney General Leslie Rutledge.

The Arkansas attorney general has filed a lawsuit accusing several drugmakers and pharmacy benefit managers of conspiring to set prices for insulin, the second time a state has taken such a step as a growing number of Americans struggle to afford the life-savings diabetes treatment.

The lawsuit alleged the companies “unfairly and deceptively” drove up the cost of insulin, making the medication unaffordable for many of the “hundreds of thousands” of state residents with diabetes and costing the state government “millions of dollars in overcharges.”

Continue to STAT+ to read the full story…